Combined use of cytology, p16 immunostaining and genotyping for triage of women positive for high‐risk human papillomavirus at primary screening-Reference-Cited by-同舟云学术

Combined use of cytology, p16 immunostaining and genotyping for triage of women positive for high‐risk human papillomavirus at primary screening

Published:2020-03-27 Issue:7 Volume:147 Page:1864-1873
ISSN:0020-7136
Container-title:International Journal of Cancer
language:en
Short-container-title:Int. J. Cancer

Author:

Cuzick Jack¹,Adcock Rachael¹^ORCID,Carozzi Francesca²,Gillio‐Tos Anna³,De Marco Laura³,Del Mistro Annarosa⁴,Frayle Helena⁴,Girlando Salvatore⁵,Sani Cristina²,Confortini Massimo²,Zorzi Manuel⁶^ORCID,Giorgi‐Rossi Paolo⁷,Rizzolo Raffaella⁸^ORCID,Ronco Guglielmo⁸⁹^ORCID,

Affiliation:

1. Wolfson Institute of Preventive Medicine, Queen Mary University of London London United Kingdom

2. Regional Cancer Prevention Laboratory, Oncological Network, Prevention and Research Institute (ISPRO) Florence Italy

3. Cancer Epidemiology Unit, Department of Medical SciencesC.E.R.M.S, University of Turin Turin Italy

4. Immunology and Diagnostic Molecular Oncology UnitVeneto Institute of Oncology IOV IRCCS Padua Italy

5. Pathology Unit, S. Chiara Hospital Trento Italy

6. Veneto Tumour Registry, Azienda Zero Padua Italy

7. Epidemiology UnitAzienda USL, IRCCS di Reggio Emilia Reggio Emilia Italy

8. Centre for Cancer PreventionAOU Città della Salute e della Scienza Torino Italy

9. International Agency for Research on Cancer (IARC) Lyon France

Funder

Associazione Italiana per la Ricerca sul Cancro

European Commission

Ministero della Salute

Publisher

Wiley

Subject

Cancer Research,Oncology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/ijc.32973

Reference25 articles.

1. Efficacy of human papillomavirus testing for the detection of invasive cervical cancers and cervical intraepithelial neoplasia: a randomised controlled trial

2. Efficacy of HPV-based screening for prevention of invasive cervical cancer: follow-up of four European randomised controlled trials

3. Evidence Regarding Human Papillomavirus Testing in Secondary Prevention of Cervical Cancer

4. Women's experiences of repeated HPV testing in the context of cervical cancer screening: a qualitative study

5. HPV16 and HPV18 genotyping in cervical cancer screening

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cancer Screening: Theory and Applications;International Encyclopedia of Public Health;2025

2. Comparison of HPV-positive triage strategies combining extended genotyping with cytology or p16/ki67 dual staining in the Italian NTCC2 study;eBioMedicine;2024-06

3. Structured Literature Review to Identify Human Papillomavirus’s Natural History Parameters for Dynamic Population Models of Vaccine Impacts;Infectious Diseases and Therapy;2024-04-08

4. Allplex HPV HR Detection assay fulfils all clinical performance and reproducibility validation requirements for primary cervical cancer screening;Journal of Clinical Virology;2024-02

5. Associations of multi-human papillomavirus infections with expression of p16 in a cohort of women who underwent colposcopy: a retrospective study of 5165 patients;Frontiers in Oncology;2023-10-26